| 产品货号 | 产品名称 | 杂志名称 | IF分 | 发表日期 | 文献链接 | 文献信息汇总 | 备注 |
|---|---|---|---|---|---|---|---|
| P42966 | pLV3-CMV-GPX4(mouse)-3×FLAG-CopGFP-Puro | FRONTIERS IN CARDIOVASCULAR MEDICINE | 2.8 | 2023-04-24 | https://doi.org/10.3389/fcvm.2023.1157752 | Yu Wang;Yan Lu;Wen Chen;Xiaohua Xie,Inhibition of ferroptosis alleviates high-power microwave-induced myocardial injury,2023-4-24,DOI:10.3389/fcvm.2023.1157752,(IF:2.8) | |
| P0256 | pLKO.1 | LIFE SCIENCES | 5.2 | 2024-11-09 | https://doi.org/10.1016/j.lfs.2024.123228 | Jinlong Cao;Siyu Chen;Jirong Wang;Xinpeng Fan;Shanhui Liu;Xiaoran Li;Li Yang,Transcription factor PRRX1-activated ANXA6 facilitates EGFR-PKCα complex formation and enhances cisplatin sensitivity in bladder cancer,2024-11-9,DOI:10.1016/j.lfs.2024.123228,(IF:5.2) | |
| P14038 | pCDH-CMV-MCS-EF1-Blast | Carcinogenesis | 3.3 | 2025-02-25 | https://doi.org/10.1093/carcin/bgae031 | Yida Lu; Bo Yang; Aolin Shen; Kexun Yu; Mengdi Ma; Yongxiang Li; Huizhen Wang,LncRNA UCA1 promotes vasculogenic mimicry by targeting miR-1-3p in gastric cancer,2025-2-25,DOI:10.1093/carcin/bgae031,(IF:3.3) | |
| P46930 | pCMV-KLF4(human)-3×FLAG-Neo | Oncogene | 6.9 | 2024-06-15 | https://doi.org/10.1038/s41388-024-03085-2 | Yichen Zang; Zhuangfei Tian; Dandan Wang; Yaxuan Li; Wenhui Zhang; Cunying Ma; Zhenzhi Liao; Wenrong Gao; Lilin Qian; Xia Xu; Jihui Jia; Zhifang Liu,METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression through regulating KLF4,2024-6-15,DOI:10.1038/s41388-024-03085-2,(IF:6.9) | |
| P0193 | pGL3-Basic | INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY | 3.2 | 2023-01-04 | https://doi.org/10.1016/j.ibmb.2023.103907 | Yaoyao Chen;Boer Hong;Yuhua Zhang;Xiaolian Chen;Tong Zhang;Guohua Zhong;Xin Yi,FoxO directly regulates the expression of odorant receptor genes to govern olfactory plasticity upon starvation in Bactrocera dorsalis,2023-1-4,DOI:10.1016/j.ibmb.2023.103907,(IF:3.2) | |
| P53006 | pLV3-CMV-KRAS(human)-G12D-mCherry-Neo | Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47 | 20.1 | 2025-06-10 | http://doi.org/10.1002/cac2.70040 | Jie Zhang,?Chen Zhang,?Ruichen Zang,?Weiwu Chen,?Yining Guo,?Haofei Jiang,?Jing Le,?Kunyu Wang,?Haobo Fan,?Xudong Wang,?Sisi Mo,?Peng Gao,?Wenhao Guo,?Xinrong Jiang,?Fengbin Gao,?Junming Jiang,?Juyan Zheng,?Yuxing Chen,?Yicheng Chen,?Yanlan Yu,?Guoqing Ding,Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47,2025-06-10,(IF:20.1) | |
| P19161 | pCAGGS-MCS | AUTOPHAGY | 14.6 | 2023-05-23 | https://doi.org/10.1080/15548627.2024.2338575 | Yueming Yuan;An Fang;Zhihui Wang;Huanchun Chen;Zhen F. Fu;Ming Zhou;Ling Zhao,The matrix protein of lyssavirus hijacks autophagosome for efficient egress by recruiting nedd4 through its ppxy motif,2023-5-23,DOI:10.1080/15548627.2024.2338575,(IF:14.6) | |
| P1761 | pRK5-HA-Ubiquitin-WT | Frontiers in cell and developmental biology | 4.6 | 2021-12-24 | https://doi.org/10.3389/fcell.2021.781792 | Qing Hou; Shuyan Kan; Yue Lang; Weibo Le; Jinsong Shi; Zhihong Liu; Zhaohong Chen; Changli Wei; Chunsun Dai,Nuclear receptor interacting protein-2 mediates the stabilization and activation of β-catenin during podocyte injury,2021-12-24,DOI:10.3389/fcell.2021.781792,(IF:4.6) | |
| P43669 | pCMV-VDAC1(mouse)-3×FLAG-WPRE-Neo | Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release | 10.3 | 2025-04-29 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12056644/ | Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release，Wenxin Zhang,Xiaohui Pan,Longsheng Wang，Wen Li， Xiaoyang Dai，Mingming Zheng，Hongjie Guo，Xi Chen，Yanjun Xu，Honghai Wu，Qiaojun He，Bo Yang，Ling Ding，J Immunother Cancer. 2025 Apr 29;13(4) | |
| P37299 | pLV2-U6-P3H1(human)-shRNA1-PGK-EGFP-Puro | Journal of oncology | 2022-10-26 | https://doi.org/10.1155/2022/7854297 | Chunlei Li; Lilong Zhang; Yao Xu; Dongqi Chai; Shengchen Nan; Zhendong Qiu; Weixing Wang; Wenhong Deng,The prognostic significance and potential mechanism of prolyl 3-hydroxylase 1 in hepatocellular carcinoma,2022-10-26,DOI:10.1155/2022/7854297,(IF:0) |
请按 Ctrl + D 键将本页加入收藏夹。
Mac 用户请按 ⌘ + D 键。
